|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Interpace Diagnostics Group Inc [IDXG]
$0.71 0.00 (0.00%)
Market Cap 30 Million
Interpace Diagnostics Group Inc is a United States-based integrated commercial and bioinformatics company. It is engaged in developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management. The company has four commercialized molecular tests, PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next-generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay, and RespriDX for assessing metastatic versus primary lung cancer tumors. The company's customers consist of physicians, hospitals, and clinics.
EPS -0.10 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Pay Date --
This list of trending stocks may change throughout the trading day.